Form D · Biotechnology
Althera Medical Ltd.
New York, NY · CIK 0001521659
Offering snapshot reported Jun 23, 2011 · SEC filing
- Reported sold
- Yet to sell Offering amount: $8M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 23, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0
- Form D file number
- 021-161735
The Company may engage registered broker dealers to offer and sell the units. Selling agents, if used, will be entitled to receive a cash fee of nor greater than 10% of the gross investments they facilitate.
Source: Form D, filed Jun 23, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Brown | Director |
| Dov Elefant | Executive |
| Steven J. Evans | Director, Executive |
| Charles Leonard Gordon | Director, Executive |
| Etan Hillman | Director |
| Yona Keisari | Executive |
| Itzhak Kelson | Executive |
| Patrick D. Lopath | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1400 Fifth Avenue
New York, NY, 10026
New York, NY, 10026